ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

VIRI Virios Therapeutics Inc

0.4279
0.0164 (3.99%)
2024年5月7日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Virios Therapeutics Inc VIRI NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0164 3.99% 0.4279 08:50:45
始値 安値 高値 終値 前日終値
0.428 0.402 0.4288 0.41 0.4115
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0222:15GLOBEVirios Therapeutics to Report First Quarter 2024 Financial..
2024/3/2622:15GLOBEVirios Therapeutics Announces Publication of International..
2024/3/0907:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2024/3/0706:30EDGAR2Form 8-K - Current report
2024/3/0123:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2923:25EDGAR2Form 8-K - Current report
2024/2/2923:15GLOBEVirios Therapeutics Announces Fourth Quarter and Full Year..
2024/2/2903:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2903:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2902:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2902:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2902:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2902:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2902:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2902:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2823:15GLOBEVirios Therapeutics Issues Shareholder Letter..
2024/2/2806:15EDGAR2Form 8-K - Current report
2024/2/0306:31EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/2223:33EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/1/2223:00GLOBEVirios Therapeutics Announces Plans to Advance..
2024/1/0321:05EDGAR2Form 8-K - Current report
2024/1/0221:05GLOBEVirios Therapeutics, Inc. Reaches Alignment with FDA on..
2023/11/1323:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1321:20EDGAR2Form 8-K - Current report
2023/11/1321:05GLOBEVirios Therapeutics Announces Third Quarter 2023 Financial..
2023/11/0721:29EDGAR2Form 8-K - Current report
2023/11/0621:05GLOBEVirios Therapeutics to Report Third Quarter 2023 Financial..
2023/11/0220:05EDGAR2Form 8-K - Current report
2023/10/1220:05GLOBEVirios Therapeutics to Present at the ThinkEquity Conference..
2023/9/1820:16EDGAR2Form 8-K - Current report
2023/9/1820:05GLOBEVirios Therapeutics Announces Termination of At-The-Market..
2023/9/1220:05GLOBEVirios Therapeutics CEO Greg Duncan to Present at the..
2023/8/2304:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1820:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1420:05GLOBEVirios Therapeutics Announces Halt to At-The-Market Offering..
2023/8/1121:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1020:15EDGAR2Form 8-K - Current report
2023/8/1020:05GLOBEVirios Therapeutics Announces Second Quarter 2023 Financial..
2023/8/0920:15EDGAR2Form 8-K - Current report
2023/8/0920:05GLOBEVirios Therapeutics Announces Plans to Advance Lead..
2023/8/0405:05GLOBEVirios Therapeutics to Report Second Quarter 2023 Financial..
2023/7/1720:15EDGAR2Form 8-K - Current report
2023/7/1720:05GLOBEVirios Therapeutics Announces Positive Data Demonstrating..
2023/7/1505:25EDGAR2Form 8-K - Current report
2023/7/1505:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/5/2605:05GLOBEVirios Therapeutics Regains Compliance with Nasdaq Minimum..
2023/5/1520:05GLOBEVirios Therapeutics Announces Submission of Final Toxicology..
2023/5/1120:05GLOBEVirios Therapeutics Announces First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock